Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ipsen S.A. ADR (IPSEY)

Ipsen S.A. ADR (IPSEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 9,595,979
  • Shares Outstanding, K 335,260
  • Annual Sales, $ 3,579 M
  • Annual Income, $ 697,430 K
  • 60-Month Beta 0.92
  • Price/Sales N/A
  • Price/Cash Flow 8.31
  • Price/Book 3.00
Trade IPSEY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 02/08/24
  • Annual Dividend & Yield 0.23 (0.81%)
  • Most Recent Dividend 0.231 on 06/02/23
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.2600 +1.63%
on 03/19/24
30.3400 -5.34%
on 04/01/24
-0.1800 (-0.62%)
since 03/18/24
3-Month
27.0000 +6.37%
on 02/13/24
30.3400 -5.34%
on 04/01/24
+0.0500 (+0.17%)
since 01/17/24
52-Week
26.9700 +6.49%
on 12/04/23
34.3380 -16.36%
on 09/13/23
+0.3600 (+1.27%)
since 04/14/23

Most Recent Stories

More News
Ipsen and Medison Pharma Announce Health Canada Approval of Bylvayâ„¢ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

/CNW/ -- Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical company focused on transformative medicines in oncology, rare disease and...

IPN : 34.71 (-0.54%)
IPSEY : 28.7200 (+0.34%)
Is Cybin Inc. (CYBN) Stock Outpacing Its Medical Peers This Year?

Here is how Cybin Inc. (CYBN) and IPSEN (IPSEY) have performed compared to their sector so far this year.

CYBN : 0.3663 (-2.42%)
IPSEY : 28.7200 (+0.34%)
Is IPSEN (IPSEY) Outperforming Other Medical Stocks This Year?

Here is how IPSEN (IPSEY) and Thermo Fisher Scientific (TMO) have performed compared to their sector so far this year.

IPSEY : 28.7200 (+0.34%)
TMO : 541.06 (-1.13%)
Ipsen Receives CHMP Negative Opinion for Palovarotene as a Treatment for Fibrodysplasia Ossificans Progressiva in E.U.

Regulatory News:

OTC.VN : 0.310 (-3.13%)
IPN : 34.71 (-0.54%)
IPSEY : 28.7200 (+0.34%)
Ipsen Presents Phase III NAPOLI 3 Trial of Onivyde® Regimen Demonstrating Positive Survival Results in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma at ASCO GI

Regulatory News:

OTC.VN : 0.310 (-3.13%)
IPN : 34.71 (-0.54%)
IPSEY : 28.7200 (+0.34%)
Why These Two Biotech Stocks Blasted Higher This Week

There's nothing like a big-premium buyout to send a company's share price to the moon.

AZN : 68.39 (-0.20%)
IPSEY : 28.7200 (+0.34%)
CINC : 29.06 (-0.48%)
ALBO : 44.15 (-0.23%)
SHAREHOLDER ALERT: Weiss Law Investigates Albireo Pharma, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Albireo Pharma, Inc....

IPSEY : 28.7200 (+0.34%)
ALBO : 44.15 (-0.23%)
2 Tiny Nasdaq Stocks Making Major Merger Moves Monday

The market is moving higher, and these small companies are helping.

COMP : 3.29 (-1.50%)
$NASX : 15,620.14 (-0.40%)
DCT : 18.99 (unch)
ALBO : 44.15 (-0.23%)
IPSEY : 28.7200 (+0.34%)
Ipsen to Acquire Albireo Accelerating Growth in Rare Disease With Treatments for Several Pediatric Liver Diseases

Regulatory News:

OTC.VN : 0.310 (-3.13%)
ALBO : 44.15 (-0.23%)
IPN : 34.71 (-0.54%)
IPSEY : 28.7200 (+0.34%)
Ipsen receives Complete Response Letter for palovarotene, an investigational treatment for fibrodysplasia ossificans progressiva

Regulatory News:

OTC.VN : 0.310 (-3.13%)
IPN : 34.71 (-0.54%)
IPSEY : 28.7200 (+0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 28.6225
2nd Resistance Point 28.6225
1st Resistance Point 28.6225
Last Price 28.7200
1st Support Level 28.6225
2nd Support Level 28.6225
3rd Support Level 28.6225

See More

52-Week High 34.3380
Fibonacci 61.8% 31.5234
Fibonacci 50% 30.6540
Fibonacci 38.2% 29.7846
Last Price 28.7200
52-Week Low 26.9700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar